Episode 5: What Comes Next?

The potential of CRISPR is enormous, but how does cutting-edge science get applied in the real world? We hear from patients on their views and the need for strong relationships with care providers. The powerful innovation also means thinking about how treatments can be made accessible, both in the US and globally, and the unique role UCSF and the UC consortium play as public institutions in Oakland clinical trial.